Abstracts accepted for ITMIG2024
Title of the abstract and the name of presenter
The list will be gradually completed
Oral Presentations
Wednesday, October 30th, 2024, 16:30 - 17:30
(AB. 4) Patterns of lymph node metastasis in patients with neuroendocrine thymic tumors: a retrospective study of 72 cases, Wenqing Zhang, China
(AB. 21) Impact of size of primary tumor on survival in thymic epithelial tumor, Asato Hashinokuchi, Japan
(AB. 69) Surveillance trends after resection for thymic malignancy, Giye Choe, USA
(AB. 77) The impact of radical or limited resection of early-stage thymoma on long-term oncologic outcome and survival: a multi-institutional retrospective study, Yi-Ting Yen, Taiwan
(AB. 49) Using Physician-Guided Artificial Intelligence to Assess Thymic Epithelial Tumors, Nirmal Choradia, USA
(AB. 65) Deep learning discriminates thymic epithelial tumors histological subtypes using Digital Pathology, Matteo Sacco, USA
Oral Presentations
Thursday, October 31st, 2024, 10:45 - 11:45
(AB. 93) Long-Term Outcomes and Characteristics of Unresectable or Inoperable Thymic Malignancies, James Huang, USA
(AB. 15) Altered thymopoiesis in the context of thymoma, Nicolas Girard, France
(AB. 59) Mediastinal lesion characterization and prognostication using diffusion MRI: from whole lesion to target zone with dynamic approach, Johan Coolen, Belgium
(AB. 29) Efgartigimod for treating thymoma-associated myasthenia gravis: A multicenter prospective observational cohort in China, Sushan Luo, China
(AB. 39) The Frequency of Druggable Genetic Alterations in Thymic Carcinoma in Younger, Middle, and Older Adult Populations in C-CAT Data, Tatsuki Ikoma, Japan
(AB. 76) SHR-1316 Plus Nab-Paclitaxel And Carboplatin as The First Line Therapy For Advanced, Unresectable, Recurrent or Metastatic Thymic Carcinoma, Ning Xu, China
Poster Presentations
POSTER EXHIBITION: Wednesday, October 30, 2024 between 13:00 and 19:00 in a room G403
(AB. 2) Late multiple extra-thoracic metastasis from thymoma biopsy seeding, Carlos Pinto, Portugal (A case selected for presentation at TUMOR BOARD)
(AB. 8) A case of mediastinal germ cell tumor with vasculogenic mesenchymal tumor components sharing a PTEN mutation with acute megakaryoblastic leukemia, Yu Naito, Japan
(AB. 10) Resection of an Epithelioid Hemangioendothelioma Arising from the Superior Vena Cava: a case report, Xiuxiu Hao, China
(AB. 11) Two cases of mediastinal germ cell tumor with somatic-type malignancy with neuroendocrine tumor, Tomoki Nishimura
(AB. 13) A case of thymic typical carcinoid successfully resected by robot-assisted thoracoscopic surgery, Akira Ogihara
(AB. 17) Surgical treatment strategy for thymic cancer invading the aorta, Yasushi Shintani, Japan
(AB. 18) Robotic thymectomy is an ideal surgical treatment for Good’s syndrome, Shinya Otsuka, Japan
(AB. 19) Extent of Thymectomy in Anti-Acetylcholine Receptor Antibody-Positive Thymoma, Yasufumi Uematsu, Japan
(AB. 22) Remarkable Long-term Survival Following Surgical Resection and Chemotherapy in Type A Thymoma with Bilateral Pulmonary Metastasis: A Rare Case Report, Wei Gan, China
(AB, 31) Superior mediastinal tumor, distribution of the diseases and its clinical course, Takao Nakanishi, Japan
(AB. 43) Primary posterior mediastinal benign leiomyoma arising from accessory hemiazygos vein, Naoto Kitahara, Japan
(AB. 46) Paraplegia as a first clinical presentation of Giant Cell Tumor of the Thoracic Spine Presenting as a Posterior Mediastinal Tumor with Cutaneous TBC, Sukarti Sukarti, Indonesia
(AB. 47) Histopathologic and Clinical Features of Mediastinal Germ Cell Tumors – Preliminary Results of An International, Multi-Institutional Study, Anja Roden, USA
(AB. 48) Insights into Hemi-Clamshell Incision for Mediastinal Tumor Resection, Chengyuan Fang, USA
(AB. 52) Short-term outcomes of uniportal subxiphoid thoracoscopic thymectomy for thymic tumors, Wang Shuai, China
(AB. 53) Metabolic profiles and clinical outcome in patients with thymic epithelial tumors, Erica Pietroluongo, Italy
(AB. 54) Clinical Outcome And Serum Cytokonome Profile In Patients With Thymic Epithelial Tumors, Erica Pietroluongo, Italy
(AB. 55) Clinical Outcome And Immunophenotype In Patients With Thymic Epithelial Tumors, Erica Pietroluongo, Italy
(AB. 58) Single-cell RNA-seq reveals altered gene expression and cellular composition in thymic epithelial cells of type B Thymoma, Nobuko Akiyama, Japan
(AB. 60) The Contribution of H.K. Müller-Hermelink to the Understanding of Human Thymic Pathology, Mirella Marino, Italy
(AB. 61) AI-powered Differentiation of Thymomas (A and B3) and Thymic Carcinoma Using Histopathological Analysis of H&E Whole Slide Images, Jan von der Thüsen, The Netherlands
(AB. 62) Thymomatous myasthenia gravis is associated with fluctuations in CD4-positive T-cell subsets through the activity of the PI3K-Akt-mTOR pathway, Shunta Ishihara, Japan
(AB. 63) Complex Management of Thymic Epithelial Tumors Associated with Immuno-Haematological Disorders at the Diagnosis, Giovannella Palmieri, Italy
(AB. 64) Thymic Epithelial Tumors and Haematological Malignancies: a monocentric experience, Giovannella Palmieri, Italy
(AB. 66) Deep dive into the NEJM study suggesting health consequences after thymectomy, Frank Detterbeck, USA
(AB. 70) Impact of relative dose intensity of platinum-base chemotherapy as first line treatment in patients with Thymic Epithelial Tumors, Erica Pietroluongo, Italy
(AB. 71) Clinical landscape and immunological features of patients with thymic carcinoma, Erica Pietroluongo, Italy
(AB. 72) Comparison of outcomes of minimally invasive surgery versus sternotomy for early-stage thymic epithelial tumors: a single-center retrospective analysis, Hiromitsu Takizawa, Japan
(AB. 73) The feasibility and efficacy of surgery followed by induction therapy for advanced thymic carcinoma, Yuriko Terada, Japan
(AB. 78) Phase II, neo-adjuvant pembrolizumab, paclitaxel, carboplatin therapy followed by post operational pembrolizumab consolidation in locally advanced thy, Sehhon Park, Republic of Korea
(AB. 80) Assessing the Predictive Significance of Tumor Size in Thymoma and Thymic Carcinoma: An Analysis Utilizing SEER Database with Propensity Matching, Wei Liu, China
(AB. 83) A case report of thymoma resection with invasion into the superior vena cava, Yuwen Bai, China
(AB.84) Tumor-T Cell Interactions in Thymic Epithelial Tumors, Laercio DaSilva, USA
(AB. 89) Rebound thymic hyperplasia and immune related adverse events: reality or fantasy, Margaret Ottaviano, Italy
(AB. 90) The antero-superior mediastinum as unique metastatic site of primary unknown desmoplastic melanoma, Margaret Ottaviano, Italy
(AB. 92) Multiplex Immunofluorescence Analysis of Potential Targets in Thymic Epithelial Tumors, Vanya Aggarwal, USA